Jones Aranthan II

CIK 00017858941 companyWASHINGTON, DC

SEC Profile

Transactions

Companies

Filings

CIK

0001785894

Recent Transactions

19 trades

Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-09-15−4,277→ 33,224 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-09-15$16.49/sh−16,824→ 81,980 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-09-15−7,842→ 47,158 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-09-15$11.32/sh+7,842→ 98,804 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-09-15$12.27/sh+4,277→ 90,962 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-07-26$19.69/sh−7,250→ 86,685 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-15$11.32/sh+15,000→ 111,935 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-15$17.72/sh−18,000→ 93,935 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-03-15−15,000→ 55,000 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-02$18.04/sh−3,865→ 96,935 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-02-24+25,800→ 101,287 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-02-24$12.27/sh+22,499→ 123,786 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-02-24$20.01/sh−22,986→ 100,800 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-02-24+61,200→ 61,200 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-02-24−22,499→ 37,501 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-08-12$11.81/sh−7,200→ 75,487 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-07-27$10.62/sh−7,313→ 82,687 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-02-26+30,000→ 90,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2020-02-26+70,000→ 70,000 total

Companies

Vanda Pharmaceuticals Inc.
Chief Corp. Affairs Officer
$VNDA

Recent Filings

Address

C/O VANDA PHARMACEUTICALS INC. 2200 PENNSYLVANIA AVENUE, SUITE 300E

WASHINGTON, DC, 20037

View on SEC.gov